My Stroke Companion - personalised digital support for stroke survivors and their families
Posted:
Cognitant Group Limited’s ‘My Stroke Companion’ is a platform that supports #stroke survivors and their families, #clinicians and #healthcare systems to overcome the challenges presented by stroke and contribute to better outcomes.
Kisqali, a key targeted therapy for breast cancer from Novartis, until now has been indicated only for patients with metastatic disease. But, the Food and Drug Administration approved Kisqali in combination with hormone therapy for patients with certain early-stage breast cancers. …
Wearable technology that monitors our bodies can be helpful and harmful.
Wearable technology affords the opportunity to check, re-check, and check again, leading to fixation.
Read the full article in the Psychology Today blog post here.